tiprankstipranks
Advertisement
Advertisement

PYPD Stock Latest News

PolyPid reports Q2 EPS (35c), consensus (38c)
The FlyPolyPid reports Q2 EPS (35c), consensus (38c)
5d ago
PYPD
PolyPid Earnings Call: Priority Review, Big Azurity Deal
PremiumCompany Announcements
PolyPid Earnings Call: Priority Review, Big Azurity Deal
10d ago
PYPD
PolyPid Posts Wider H1 2026 Loss as Assets and Equity Decline
PremiumCompany Announcements
PolyPid Posts Wider H1 2026 Loss as Assets and Equity Decline
10d ago
6K
PYPD
PolyPid Wins FDA Priority Review for D-PLEX₁₀₀ and Locks In $30 Million Azurity Milestones
PremiumCompany Announcements
PolyPid Wins FDA Priority Review for D-PLEX₁₀₀ and Locks In $30 Million Azurity Milestones
10d ago
6K
PYPD
PYPD Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PYPD Earnings this Week: How Will it Perform?
12d ago
PYPD
PolyPid NDA acceptance ‘meets or exceeds’ expectations, says Roth Capital
PremiumThe FlyPolyPid NDA acceptance ‘meets or exceeds’ expectations, says Roth Capital
24d ago
PYPD
PolyPid announces FDA acceptance of, priority review for D-PLEX100
Premium
The Fly
PolyPid announces FDA acceptance of, priority review for D-PLEX100
24d ago
PYPD
PolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market
Premium
Company Announcements
PolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market
24d ago
6K
PYPD
PolyPid price target lowered to $12 from $13 at Craig-Hallum
PremiumThe Fly
PolyPid price target lowered to $12 from $13 at Craig-Hallum
1M ago
PYPD
Roth says Azurity deal validates D-PLEX100, sees limited near-term revenue
PremiumThe Fly
Roth says Azurity deal validates D-PLEX100, sees limited near-term revenue
1M ago
PYPD
PolyPid Locks in a Transformative Deal Worth Over $320 Million, With Additional Major Royalty Potential
PremiumTipRanks Newswire
PolyPid Locks in a Transformative Deal Worth Over $320 Million, With Additional Major Royalty Potential
1M ago
PYPD
PolyPid Stock (PYPD) Plummets Despite Deal With Azurity to Tackle Surgical Infections
PremiumMarket News
PolyPid Stock (PYPD) Plummets Despite Deal With Azurity to Tackle Surgical Infections
1M ago
PYPD
PolyPid Strikes Azurity Commercialization Deal for D-PLEX100 in U.S. and Canada
PremiumCompany AnnouncementsPolyPid Strikes Azurity Commercialization Deal for D-PLEX100 in U.S. and Canada
1M ago
6K
PYPD
PolyPid enters exclusive pact with Azurity Pharmaceuticals for D-PLEX100
Premium
The Fly
PolyPid enters exclusive pact with Azurity Pharmaceuticals for D-PLEX100
1M ago
PYPD
Surgical Infections Cost Hospitals Billions. One Under-the-Radar Biotech Player Might be About to Change That
Premium
TipRanks Newswire
Surgical Infections Cost Hospitals Billions. One Under-the-Radar Biotech Player Might be About to Change That
1M ago
LLY
NXTC
Lilly’s $780M Bet is Reshaping Surgical Infection Prevention, and PolyPid’s Asset is Hiding in Plain Sight
PremiumTipRanks Newswire
Lilly’s $780M Bet is Reshaping Surgical Infection Prevention, and PolyPid’s Asset is Hiding in Plain Sight
2M ago
LLY
PYPD
PolyPid Sets July 15, 2026 Shareholder Meeting to Vote on Board, Auditor and Equity Grants
PremiumCompany Announcements
PolyPid Sets July 15, 2026 Shareholder Meeting to Vote on Board, Auditor and Equity Grants
2M ago
6K
PYPD
PolyPid completes NDA submission to FDA for D-PLEX100
PremiumThe Fly
PolyPid completes NDA submission to FDA for D-PLEX100
3M ago
PYPD
PolyPid Files NDA with FDA for Lead Infection-Prevention Drug D-PLEX100
PremiumCompany Announcements
PolyPid Files NDA with FDA for Lead Infection-Prevention Drug D-PLEX100
3M ago
6K
PYPD
PolyPid’s Earnings Call Signals Tightrope to Approval
PremiumCompany AnnouncementsPolyPid’s Earnings Call Signals Tightrope to Approval
3M ago
PYPD
PolyPid Earnings Call: NDA Momentum Amid Cash Strain
Premium
Company Announcements
PolyPid Earnings Call: NDA Momentum Amid Cash Strain
3M ago
PYPD
PolyPid reports Q1 EPS (35c), consensus (43c)
Premium
The Fly
PolyPid reports Q1 EPS (35c), consensus (43c)
3M ago
PYPD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >